Allopurinol
Product Images NDC 43353-088

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 43353-088). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 300mg (43353 0088 60)

This is a package of Allopurinol medication, containing 90 tablets of 300mg each. It is manufactured by Dr. Reddys Laboratories Louisiana and repackaged by Aphena Pharma in Cookeville. The package has a unique identifier NDC # 43353-0088-60 and N 43353-0088-60. The medication should be stored between 20-25 degrees Celsius and out of reach of children.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Structure (Structure)

FDA Label Image

Structure2 (Structure2)

Allopurinol and Oxipurinol are compounds with complex chemical structures containing pyrazolo and purine rings. Allopurinol is converted into Oxipurinol in the body and both compounds are used in the treatment of gout and kidney stones. They act by inhibiting the enzyme xanthine oxidase, which is responsible for the production of uric acid. Uric acid is a waste product that is normally excreted from the body, but an excess can accumulate and cause pain and inflammation associated with gout and kidney stones.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.